Conagra Brands, the parent company behind labels like Healthy Choice and Marie Callender’s, is adjusting its marketing strategy to align with the rising popularity of GLP-1 weight-loss drugs. The company plans to introduce "GLP-1 friendly" labeling on certain food products to target shoppers who are actively managing their caloric intake while using medications such as Ozempic or Wegovy. This strategic pivot comes as food manufacturers face concerns that widespread use of these drugs could lead to a long-term decline in overall food consumption.

By highlighting specific nutritional profiles—such as high protein or controlled portion sizes—Conagra hopes to retain customers who might otherwise reduce their spending on processed or frozen foods. While the company views this as a proactive way to adapt to shifting health trends, the move also reflects broader industry anxiety regarding how pharmaceutical interventions might permanently alter consumer demand. Conagra has not yet specified which exact products will carry the new branding, but the initiative signals a broader trend of legacy food companies attempting to reposition their portfolios to remain relevant in a market increasingly influenced by medical weight-management solutions.